Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting
- 1 April 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 89 (8) , 937-940
- https://doi.org/10.1016/s0002-9149(02)02242-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting EnzymeCirculation, 1998
- Patterns and Mechanisms of In-Stent RestenosisCirculation, 1996
- Pharmacological Strategies to Prevent RestenosisCirculation, 1996
- Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazaprilJournal of the American College of Cardiology, 1995
- Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.Circulation, 1994
- Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury modelAmerican Heart Journal, 1993
- Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circulation Research, 1991
- Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular InjuryScience, 1989
- Effects of angiotensin II and vasopressin on human smooth muscle cells in vitroExperimental and Molecular Pathology, 1981